IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening.
Saved in:
| Title: | IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening. |
|---|---|
| Authors: | Pohly MF; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Putzker K; Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany., Scheinost S; Molecular Therapy in Hematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Ben Taarit L; Molecular Therapy in Hematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Walther T; Molecular Therapy in Hematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Kummer S; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Wertheimer T; Department of Inflammation Research, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Lin M; Department of Inflammation Research, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Do THL; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Handler K; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Michler J; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Kivioja J; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Bach K; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Kisele S; Department of Pediatric Oncology, University Children's Hospital, University of Zurich, Zurich, Switzerland., Kim J; Department of Pediatric Oncology, University Children's Hospital, University of Zurich, Zurich, Switzerland., Dietrich S; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, University Hospital of Düsseldorf, Düsseldorf, Germany., Bornhauser B; Department of Pediatric Oncology, University Children's Hospital, University of Zurich, Zurich, Switzerland., Wong WW; Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland., Becher B; Department of Inflammation Research, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Moor A; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Lewis J; Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.; Anavo Therapeutics, Heidelberg, Germany., Ficht X; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Lu J; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany., Huber W; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany., Zenz T; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland. |
| Source: | Blood [Blood] 2025 May 15; Vol. 145 (20), pp. 2336-2352. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39869826 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pohly+MF%22">Pohly MF</searchLink>; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Putzker+K%22">Putzker K</searchLink>; Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Scheinost+S%22">Scheinost S</searchLink>; Molecular Therapy in Hematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Ben+Taarit+L%22">Ben Taarit L</searchLink>; Molecular Therapy in Hematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Walther+T%22">Walther T</searchLink>; Molecular Therapy in Hematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Kummer+S%22">Kummer S</searchLink>; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wertheimer+T%22">Wertheimer T</searchLink>; Department of Inflammation Research, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lin+M%22">Lin M</searchLink>; Department of Inflammation Research, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Do+THL%22">Do THL</searchLink>; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Handler+K%22">Handler K</searchLink>; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Michler+J%22">Michler J</searchLink>; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kivioja+J%22">Kivioja J</searchLink>; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bach+K%22">Bach K</searchLink>; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kisele+S%22">Kisele S</searchLink>; Department of Pediatric Oncology, University Children's Hospital, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kim+J%22">Kim J</searchLink>; Department of Pediatric Oncology, University Children's Hospital, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dietrich+S%22">Dietrich S</searchLink>; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, University Hospital of Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Bornhauser+B%22">Bornhauser B</searchLink>; Department of Pediatric Oncology, University Children's Hospital, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wong+WW%22">Wong WW</searchLink>; Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Becher+B%22">Becher B</searchLink>; Department of Inflammation Research, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Moor+A%22">Moor A</searchLink>; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lewis+J%22">Lewis J</searchLink>; Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.; Anavo Therapeutics, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Ficht+X%22">Ficht X</searchLink>; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lu+J%22">Lu J</searchLink>; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Huber+W%22">Huber W</searchLink>; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Zenz+T%22">Zenz T</searchLink>; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2025 May 15; Vol. 145 (20), pp. 2336-2352. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39869826 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood.2024027171 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2336 Titles: – TitleFull: IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pohly MF – PersonEntity: Name: NameFull: Putzker K – PersonEntity: Name: NameFull: Scheinost S – PersonEntity: Name: NameFull: Ben Taarit L – PersonEntity: Name: NameFull: Walther T – PersonEntity: Name: NameFull: Kummer S – PersonEntity: Name: NameFull: Wertheimer T – PersonEntity: Name: NameFull: Lin M – PersonEntity: Name: NameFull: Do THL – PersonEntity: Name: NameFull: Handler K – PersonEntity: Name: NameFull: Michler J – PersonEntity: Name: NameFull: Kivioja J – PersonEntity: Name: NameFull: Bach K – PersonEntity: Name: NameFull: Kisele S – PersonEntity: Name: NameFull: Kim J – PersonEntity: Name: NameFull: Dietrich S – PersonEntity: Name: NameFull: Bornhauser B – PersonEntity: Name: NameFull: Wong WW – PersonEntity: Name: NameFull: Becher B – PersonEntity: Name: NameFull: Moor A – PersonEntity: Name: NameFull: Lewis J – PersonEntity: Name: NameFull: Ficht X – PersonEntity: Name: NameFull: Lu J – PersonEntity: Name: NameFull: Huber W – PersonEntity: Name: NameFull: Zenz T IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 05 Text: 2025 May 15 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1528-0020 Numbering: – Type: volume Value: 145 – Type: issue Value: 20 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |